Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric-Type Follicular Lymphoma”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Post-approval studies (Phase 4)Study completedNCT01982539
What this trial is testing

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Who this might be right for
Pain
Depomed 25
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Testing effectiveness (Phase 2)UnknownNCT00737685
What this trial is testing

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

Who this might be right for
Anemia, Aplastic
The Korean Society of Pediatric Hematology Oncology 30
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Early research (Phase 1)Study completedNCT02315612
What this trial is testing

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Who this might be right for
NHLLarge Cell LymphomaFollicular Lymphoma+7 more
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Looking for participantsNCT03676504
What this trial is testing

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Who this might be right for
Acute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, PediatricChronic Lymphocytic Leukemia+3 more
University Hospital Heidelberg 68
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Post-approval studies (Phase 4)Study completedNCT02328651
What this trial is testing

Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease

Who this might be right for
Handfoot-mouth Disease
Children's Hospital of Fudan University 24
Not applicableStudy completedNCT00050193
What this trial is testing

Cause and Natural Course of Pediatric-Onset Mastocytosis

Who this might be right for
Mastocytosis
National Institute of Allergy and Infectious Diseases (NIAID) 103
Not applicableStudy completedNCT00282516
What this trial is testing

Asthma In-Home Monitoring (AIM) Trial

Who this might be right for
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Tripler Army Medical Center 120
Post-approval studies (Phase 4)Study completedNCT01745159
What this trial is testing

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Who this might be right for
Moderate/Severe Atopic Dermatitis
Astellas Pharma China, Inc. 125
Post-approval studies (Phase 4)Study completedNCT02287350
What this trial is testing

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Who this might be right for
Pain
Depomed 51
Large-scale testing (Phase 3)Study completedNCT02093663
What this trial is testing

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 107
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46